1. H.W. Smith 1978 Is it safe to use Escherichia coli K 12 in recombinant DNA experiments? J Infect Dis 137 655 660.

1. H.W. Smith 1978 Is it safe to use Escherichia coli K 12 in recombinant DNA experiments? J Infect Dis 137 655 660.)| false
• Search Google Scholar
• Export Citation

2. R. Curtiss 3rd 1978 Biological containment and cloning vector transmissibility J Infect Dis 137 668 675.

2. R. Curtiss 3rd 1978 Biological containment and cloning vector transmissibility J Infect Dis 137 668 675.)| false
• Search Google Scholar
• Export Citation

3. J. Lederberg E.L. Tatum 1946 Gene recombination in Escherichia coli Nature 158 558.

3. J. Lederberg E.L. Tatum 1946 Gene recombination in Escherichia coli Nature 158 558.)| false
• Search Google Scholar
• Export Citation

4. H.W. Smith 1975 Survival of orally administered E. coli K 12 in alimentary tract of man Nature 255 500 502.

4. H.W. Smith 1975 Survival of orally administered E. coli K 12 in alimentary tract of man Nature 255 500 502.)| false
• Search Google Scholar
• Export Citation

5. A.K. Moller M.P. Leatham T. Conway P.J. Nuijten L.A. de Haan et al.2003 An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine Infect Immun 71 2142 2152.

5. A.K. Moller M.P. Leatham T. Conway P.J. Nuijten L.A. de Haan 2003 An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine Infect Immun 71 2142 2152.)| false
• Search Google Scholar
• Export Citation

6. Hayashi K , Morooka N, Yamamoto Y, Fujita K, Isono K et al.: Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol 2006. 0007 (2006).

6. Hayashi K , MorookaN, YamamotoY, FujitaK, IsonoK et al.: Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol2006. 0007 (2006).)| false
• Search Google Scholar
• Export Citation

7. R. Lodinova-Zadnikova U. Sonnenborn 1997 Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants Biol Neonate 71 224 232.

7. R. Lodinova-Zadnikova U. Sonnenborn 1997 Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants Biol Neonate 71 224 232.)| false
• Search Google Scholar
• Export Citation

8. F. Shanahan 2000 Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis 6 107 115.

8. F. Shanahan 2000 Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis 6 107 115.)| false
• Search Google Scholar
• Export Citation

9. F. Shanahan 2001 Probiotics in inflammatory bowel disease Gut 48 609.

9. F. Shanahan 2001 Probiotics in inflammatory bowel disease Gut 48 609.)| false
• Search Google Scholar
• Export Citation

10. A. Nissle 1918 Die antagonistische Behandlung chronischer Darmstörungen mit Colibekaterien Med Klin 2 29 30.

10. A. Nissle 1918 Die antagonistische Behandlung chronischer Darmstörungen mit Colibekaterien Med Klin 2 29 30.)| false
• Search Google Scholar
• Export Citation

11. G. Blum R. Marre J. Hacker 1995 Properties of Escherichia coli strains of serotype O6 Infection 23 234 236.

11. G. Blum R. Marre J. Hacker 1995 Properties of Escherichia coli strains of serotype O6 Infection 23 234 236.)| false
• Search Google Scholar
• Export Citation

12. J. Henker M. Laass B.M. Blokhin Y.K. Bolbot V.G. Maydannik et al.2007 The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers Eur J Pediatr 166 311 318.

12. J. Henker M. Laass B.M. Blokhin Y.K. Bolbot V.G. Maydannik 2007 The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers Eur J Pediatr 166 311 318.)| false
• Search Google Scholar
• Export Citation

13. W. Kruis P. Fric J. Pokrotnieks M. Lukas B. Fixa et al.2004 Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Gut 53 1617 1623.

13. W. Kruis P. Fric J. Pokrotnieks M. Lukas B. Fixa 2004 Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Gut 53 1617 1623.)| false
• Search Google Scholar
• Export Citation

14. S. Fujimori A. Tatsuguchi K. Gudis T. Kishida K. Mitsui et al.2007 High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease J Gastroenterol Hepatol 22 1199 1204.

14. S. Fujimori A. Tatsuguchi K. Gudis T. Kishida K. Mitsui 2007 High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease J Gastroenterol Hepatol 22 1199 1204.)| false
• Search Google Scholar
• Export Citation

15. O. Liesenfeld J. Kosek J.S. Remington Y. Suzuki 1996 Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii J Exp Med 184 597 607.

15. O. Liesenfeld J. Kosek J.S. Remington Y. Suzuki 1996 Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii J Exp Med 184 597 607.)| false
• Search Google Scholar
• Export Citation

16. O. Liesenfeld 2002 Oral infection of C 57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 185Suppl1 S96 S101.

16. O. Liesenfeld 2002 Oral infection of C 57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 185Suppl1 S96 S101.)| false
• Search Google Scholar
• Export Citation

17. M.M. Heimesaat S. Bereswill A. Fischer D. Fuchs D. Struck et al.2006 Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii J Immunol 177 8785 8795.

17. M.M. Heimesaat S. Bereswill A. Fischer D. Fuchs D. Struck 2006 Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii J Immunol 177 8785 8795.)| false
• Search Google Scholar
• Export Citation

18. I.A. Khan J.D. Schwartzman T. Matsuura L.H. Kasper 1997 A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice Proc Natl Acad Sci U S A 94 13955 13960.

18. I.A. Khan J.D. Schwartzman T. Matsuura L.H. Kasper 1997 A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice Proc Natl Acad Sci U S A 94 13955 13960.)| false
• Search Google Scholar
• Export Citation

19. F.J. Mennechet L.H. Kasper N. Rachinel W. Li A. Vandewalle et al.2002 Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen J Immunol 168 2988 2996.

19. F.J. Mennechet L.H. Kasper N. Rachinel W. Li A. Vandewalle 2002 Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen J Immunol 168 2988 2996.)| false
• Search Google Scholar
• Export Citation

20. O. Liesenfeld H. Kang D. Park T.A. Nguyen C.V. Parkhe et al.1999 TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii Parasite Immunol 21 365 376.

20. O. Liesenfeld H. Kang D. Park T.A. Nguyen C.V. Parkhe 1999 TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii Parasite Immunol 21 365 376.)| false
• Search Google Scholar
• Export Citation

21. A. Vossenkamper D. Struck C. Alvarado-Esquivel T. Went K. Takeda et al.2004 Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control Eur J Immunol 34 3197 3207.

21. A. Vossenkamper D. Struck C. Alvarado-Esquivel T. Went K. Takeda 2004 Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control Eur J Immunol 34 3197 3207.)| false
• Search Google Scholar
• Export Citation

22. M. Munoz M.M. Heimesaat K. Danker D. Struck U. Lohmann et al.2009 Interleukin (IL)-23 mediates Toxoplasma gondiiinduced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. 2 and IL-22 but independent of IL-17 J Exp Med 206 3047 3059.

22. M. Munoz M.M. Heimesaat K. Danker D. Struck U. Lohmann 2009 Interleukin (IL)-23 mediates Toxoplasma gondiiinduced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. 2 and IL-22 but independent of IL-17 J Exp Med 206 3047 3059.)| false
• Search Google Scholar
• Export Citation

23. D. Struck I. Frank S. Enders U. Steinhoff C. Schmidt A. Stallmach O. Liesenfeld M.M. Heimesaat 2012 Treatment with Interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived Interleukin-18 Eur J Microbiol Immunol 2 249 257.

23. D. Struck I. Frank S. Enders U. Steinhoff C. Schmidt A. Stallmach O. Liesenfeld M.M. Heimesaat 2012 Treatment with Interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived Interleukin-18 Eur J Microbiol Immunol 2 249 257.)| false
• Search Google Scholar
• Export Citation

24. M.M. Heimesaat A. Fischer H.K. Jahn J. Niebergall M. Freudenberg et al.2007 Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli Gut 56 941 948.

24. M.M. Heimesaat A. Fischer H.K. Jahn J. Niebergall M. Freudenberg 2007 Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli Gut 56 941 948.)| false
• Search Google Scholar
• Export Citation

25. C. Erridge S.H. Duncan S. Bereswill M.M. Heimesaat 2010 The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5 PLoS One 5 e9125.

25. C. Erridge S.H. Duncan S. Bereswill M.M. Heimesaat 2010 The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5 PLoS One 5 e9125.)| false
• Search Google Scholar
• Export Citation

26. Haag LM , Fischer A, Otto B, Plickert R, Kühl AA et al.: Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One 7, e35988 (2012).

26. Haag LM , FischerA, OttoB, PlickertR, KühlAA et al.: Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One7, e35988 (2012).)| false
• Search Google Scholar
• Export Citation

27. M.M. Heimesaat A. Fischer B. Siegmund A. Kupz J. Niebergall et al.2007 Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4 PLoS One 2 e662.

27. M.M. Heimesaat A. Fischer B. Siegmund A. Kupz J. Niebergall 2007 Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4 PLoS One 2 e662.)| false
• Search Google Scholar
• Export Citation

28. M.M. Heimesaat A. Nogai S. Bereswill R. Plickert A. Fischer et al.2010 MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease Gut 59 1079 1087.

28. M.M. Heimesaat A. Nogai S. Bereswill R. Plickert A. Fischer 2010 MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease Gut 59 1079 1087.)| false
• Search Google Scholar
• Export Citation

29. S. Bereswill M. Munoz A. Fischer R. Plickert L.M. Haag et al.2010 Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation PLoS One 5 e15099.

29. S. Bereswill M. Munoz A. Fischer R. Plickert L.M. Haag 2010 Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation PLoS One 5 e15099.)| false
• Search Google Scholar
• Export Citation

30. L.M. Haag A. Fischer B. Otto U. Grundmann A.A. Kühl et al.2012 Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune response Eur J Microbiol Immunol 2 2 11.

30. L.M. Haag A. Fischer B. Otto U. Grundmann A.A. Kühl 2012 Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune response Eur J Microbiol Immunol 2 2 11.)| false
• Search Google Scholar
• Export Citation

31. Bereswill S , Fischer A, Plickert R, Haag LM, Otto B et al.: Novel murine infection models provide deep insights into the “menage a trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One 6, e20953 (2011).

31. Bereswill S , FischerA, PlickertR, HaagLM, OttoB et al.: Novel murine infection models provide deep insights into the “menage a trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One6, e20953 (2011).)| false
• Search Google Scholar
• Export Citation

32. P.I. Zigra V.E. Maipa Y.P. Alamanos 2007 Probiotics and remission of ulcerative colitis: a systematic review Neth J Med 65 411 418.

32. P.I. Zigra V.E. Maipa Y.P. Alamanos 2007 Probiotics and remission of ulcerative colitis: a systematic review Neth J Med 65 411 418.)| false
• Search Google Scholar
• Export Citation

33. A.C. Senok A.Y. Ismaeel G.A. Botta 2005 Probiotics: facts and myths Clin Microbiol Infect 11 958 966.

33. A.C. Senok A.Y. Ismaeel G.A. Botta 2005 Probiotics: facts and myths Clin Microbiol Infect 11 958 966.)| false
• Search Google Scholar
• Export Citation

34. S. Lebeer J. Vanderleyden S.C. De Keersmaecker 2010 Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens Nat Rev Microbiol 8 171 184.

34. S. Lebeer J. Vanderleyden S.C. De Keersmaecker 2010 Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens Nat Rev Microbiol 8 171 184.)| false
• Search Google Scholar
• Export Citation

35. I. Trebichavsky I. Splichal V. Rada A. Splichalova 2010 Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917 Nutr Rev 68 459 464.

35. I. Trebichavsky I. Splichal V. Rada A. Splichalova 2010 Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917 Nutr Rev 68 459 464.)| false
• Search Google Scholar
• Export Citation

36. A. Bleich J.P. Sundberg A. Smoczek R. von Wasielewski M.F. de Buhr et al.2008 Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background Int J Exp Pathol 89 45 54.

36. A. Bleich J.P. Sundberg A. Smoczek R. von Wasielewski M.F. de Buhr 2008 Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background Int J Exp Pathol 89 45 54.)| false
• Search Google Scholar
• Export Citation

37. S.N. Ukena A.M. Westendorf W. Hansen M. Rohde R. Geffers et al.2005 The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1 BMC Med Genet 6 43.

37. S.N. Ukena A.M. Westendorf W. Hansen M. Rohde R. Geffers 2005 The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1 BMC Med Genet 6 43.)| false
• Search Google Scholar
• Export Citation

38. R.A. Welch V. Burland G. Plunkett 3rd P. Redford P. Roesch et al.2002 Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli Proc Natl Acad Sci U S A 99 17020 17024.

38. R.A. Welch V. Burland G. Plunkett 3rd P. Redford P. Roesch 2002 Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli Proc Natl Acad Sci U S A 99 17020 17024.)| false
• Search Google Scholar
• Export Citation

39. L. Grozdanov C. Raasch J. Schulze U. Sonnenborn G. Gottschalk et al.2004 Analysis of the genome structure of the non-pathogenic probiotic Escherichia coli strain Nissle 1917 J Bacteriol 186 5432 5441.

39. L. Grozdanov C. Raasch J. Schulze U. Sonnenborn G. Gottschalk 2004 Analysis of the genome structure of the non-pathogenic probiotic Escherichia coli strain Nissle 1917 J Bacteriol 186 5432 5441.)| false
• Search Google Scholar
• Export Citation

40. J. Sun F. Gunzer A.M. Westendorf J. Buer M. Scharfe et al.2005 Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data J Biotechnol 117 147 161.

40. J. Sun F. Gunzer A.M. Westendorf J. Buer M. Scharfe 2005 Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data J Biotechnol 117 147 161.)| false
• Search Google Scholar
• Export Citation

41. E. Adam L. Delbrassine C. Bouillot V. Reynders A.C. Mailleux et al.2010 Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway Eur J Immunol 40 1995 2005.

41. E. Adam L. Delbrassine C. Bouillot V. Reynders A.C. Mailleux 2010 Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway Eur J Immunol 40 1995 2005.)| false
• Search Google Scholar
• Export Citation

42. H.S. Warren C. Fitting E. Hoff M. Adib-Conquy L. Beasley-Topliffe et al.2010 Resilience to bacterial infection: difference between species could be due to proteins in serum J Infect Dis 201 223 232.

42. H.S. Warren C. Fitting E. Hoff M. Adib-Conquy L. Beasley-Topliffe 2010 Resilience to bacterial infection: difference between species could be due to proteins in serum J Infect Dis 201 223 232.)| false
• Search Google Scholar
• Export Citation

43. K. Guenther E. Straube W. Pfister A. Guenther A. Huebler 2010 Severe sepsis after probiotic treatment with Escherichia coli NISSLE 1917 Pediatr Infect Dis J 29 188 189.

43. K. Guenther E. Straube W. Pfister A. Guenther A. Huebler 2010 Severe sepsis after probiotic treatment with Escherichia coli NISSLE 1917 Pediatr Infect Dis J 29 188 189.)| false
• Search Google Scholar
• Export Citation